BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
US9545086B2 · kind B2 · utility
10Cited by
13References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2008 |
| Grant date | Jan 17, 2017 |
| Priority date | — |
| Expiry date | Sep 4, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for treating or preventing disorders associated with expression of BAFF comprising BAFF and fragments thereof, antibodies, agonists and antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.